Pharmaceutical Group Introduction
Actoverco Pharmaceutical Company
Actover and youth
Actoverco Company, employing more than 2,000 of the country’s most efficient young people, in 15 therapeutic areas and with a range of more than 320 pharmaceutical products, in accordance with the highest standards approved by domestic and international organizations, has so far been able to form the largest and most experienced private pharmaceutical group in Iran and the Middle East in the production and supply of medicines, with many honors. Actoverco was founded with the aim of producing and meeting the pharmaceutical needs of Iranian patients in achieving the best quality, at a world-class level, and has always been one of the leading companies in producing the best medicines in the Iranian and regional markets.
This group, by producing the highest amount of tablets, capsules, syringes, vials and ampoules, has one of the largest production lines for finished medicines in the country. Providing and employing the most equipped production machinery based on the latest technology in the field of oral and injectable medicines, the most advanced and equipped production lines for anti-cancer, transplant, hormonal and fertility drugs, along with transferring technical knowledge and using the capacities available in the country, has been part of Actover Group’s efforts to increase job creation and boost national production.
Actover therapeutic areas
Currently, the pharmaceutical sector with 43 thousand square meters of production space and 18 production lines for tablets and capsules with a capacity of more than 7 billion units per year, 5 production lines for pre-filled vials and syringes with a capacity of 60 million units, the largest production line for ampoules with a capacity of 50 million units, 3 production lines for lyophilized products with a capacity of 5 million units, and 4 production lines with Bioreactor with a capacity of 2000 liters, and presence in more than 15 therapeutic areas and production of pharmaceutical raw materials and supplements has reached the goals set at the beginning. With new goals, it has once again initiated fundamental changes in the pharmaceutical and therapeutic space of the country. At the very beginning, Actover’s effective presence in supplying corona drugs and successful entry into the club of vaccine makers in the world are signs of this new beginning. Therefore, Actover’s productions are carried out at the sites of Actover 1, Actover 2, Actover Bio (biosimilar products), Actover (the most equipped site for producing oncology products), Ati Pharmed (the only holder of GMP certificate in hormonal drugs), Alborz Zagros (the only site with OEL5 in the production of hazardous drugs), Octovercell Gene (personalized medicine), Octobiome (active pharmaceutical ingredients), and Nexus (supplements) produce drugs for cardiovascular, neurology, asthma and allergies, diabetes, oncology, MS, urology, gynecology and infertility, organ transplantation, supplements, digestion, fat and metabolism, painkillers, neurology and psychology, skin and hair and beauty, infectious diseases, and Covid-19, active pharmaceutical ingredients. Also, by establishing the Octotech accelerator, it tried to cover the gap in industry-university communication so that academic projects and industry needs can emerge and accelerate in a reciprocal manner.
Charity of the late Dr. Mustafa Naraqi
Actover Group pursued its social responsibility activities by establishing Dr. Naraghi Charity Foundation and being on the Board of Trustees of Kahrizak. It tried to take fundamental steps in the field of education by building and establishing specialized schools and art schools in Tehran, Karaj and Mashhad. Covering needy families and orphaned children in Dr. Naraghi’s orphanage and creating a communication link for the treatment and surgery of injured children in Iran and neighboring countries are other actions of Actover Group. In recent years, Actover’s relief activities, especially treatment, in all natural disasters and calamities, along with food, medicine, clothing and basic necessities of life, and efforts to provide stationery and toys for children in these areas, along with the presence of specialized teams in the Kermanshah and Sarpol Zahab earthquakes, the Lorestan and Khuzestan floods, as well as the Baluchistan floods, and providing relief to the dear people of the country have been other actions of Actover. Identifying deprived areas of the country approximately twice a year with the executive teams of Dr. Naraghi’s charity and the support of Actuator and Amad Ladiz in these areas, including South Khorasan (Firdous), Azerbaijan (Qara Aghaj), and the Ilam highlands.
Actover's social responsibilities
Developing the medical and hospital sector by identifying children in need of serious medical attention throughout the country and providing full support until the patient’s condition improves, and recently, Iraqi and Afghan children who suffered from war or genetic accidents, and thanks to Dr. Naraqi’s charitable support, we were able to introduce them to medical centers and begin their treatment. In general, any child from anywhere in the country and recently abroad who needs medical, surgical or pharmaceutical support is supported by Dr. Naraqi’s charity.
With the outbreak of COVID-19, in addition to providing personal protective clothing (PPE) and producing disinfectant solutions and donating them to medical centers and deprived areas, it also provided medicines such as Tamiflu and Kaletra and distributed them quickly in the first days of the outbreak. At the same time, it started preparations for the production of special Corona medicines with international manufacturers. This led to the finalization of the production process of these products in the country in the shortest possible time. In addition to self-sufficiency in production, it provides these products to our dear people with a capacity of more than 30 million favipiravir tablets and 300,000 vials of remdesivir per month, at a price of less than one-fifteenth. With the beginning of the global effort to provide the Corona vaccine, this company, as the first holder of the technical knowledge to produce this vaccine in the Middle East, succeeded in producing the Russian Sputnik vaccine in Iran.
Actover and youth
Actoverco Company, employing more than 2,000 of the country’s most efficient young people, in 15 therapeutic areas and with a range of more than 320 pharmaceutical products, in accordance with the highest standards approved by domestic and international organizations, has so far been able to form the largest and most experienced private pharmaceutical group in Iran and the Middle East in the production and supply of medicines, with many honors. Actoverco was founded with the aim of producing and meeting the pharmaceutical needs of Iranian patients in achieving the best quality, at a world-class level, and has always been one of the leading companies in producing the best medicines in the Iranian and regional markets.
This group, by producing the highest amount of tablets, capsules, syringes, vials and ampoules, has one of the largest production lines for finished medicines in the country. Providing and employing the most equipped production machinery based on the latest technology in the field of oral and injectable medicines, the most advanced and equipped production lines for anti-cancer, transplant, hormonal and fertility drugs, along with transferring technical knowledge and using the capacities available in the country, has been part of Actover Group’s efforts to increase job creation and boost national production.
Actover therapeutic areas
Currently, the pharmaceutical sector with 43 thousand square meters of production space and 18 production lines for tablets and capsules with a capacity of more than 7 billion units per year, 5 production lines for pre-filled vials and syringes with a capacity of 60 million units, the largest production line for ampoules with a capacity of 50 million units, 3 production lines for lyophilized products with a capacity of 5 million units, and 4 production lines with Bioreactor with a capacity of 2000 liters, and presence in more than 15 therapeutic areas and production of pharmaceutical raw materials and supplements has reached the goals set at the beginning. With new goals, it has once again initiated fundamental changes in the pharmaceutical and therapeutic space of the country. At the very beginning, Actover’s effective presence in supplying corona drugs and successful entry into the club of vaccine makers in the world are signs of this new beginning. Therefore, Actover’s productions are carried out at the sites of Actover 1, Actover 2, Actover Bio (biosimilar products), Actover (the most equipped site for producing oncology products), Ati Pharmed (the only holder of GMP certificate in hormonal drugs), Alborz Zagros (the only site with OEL5 in the production of hazardous drugs), Octovercell Gene (personalized medicine), Octobiome (active pharmaceutical ingredients), and Nexus (supplements) produce drugs for cardiovascular, neurology, asthma and allergies, diabetes, oncology, MS, urology, gynecology and infertility, organ transplantation, supplements, digestion, fat and metabolism, painkillers, neurology and psychology, skin and hair and beauty, infectious diseases, and Covid-19, active pharmaceutical ingredients. Also, by establishing the Octotech accelerator, it tried to cover the gap in industry-university communication so that academic projects and industry needs can emerge and accelerate in a reciprocal manner.
Charity of the late Dr. Mustafa Naraqi
Actover Group pursued its social responsibility activities by establishing Dr. Naraghi Charity Foundation and being on the Board of Trustees of Kahrizak. It tried to take fundamental steps in the field of education by building and establishing specialized schools and art schools in Tehran, Karaj and Mashhad. Covering needy families and orphaned children in Dr. Naraghi’s orphanage and creating a communication link for the treatment and surgery of injured children in Iran and neighboring countries are other actions of Actover Group. In recent years, Actover’s relief activities, especially treatment, in all natural disasters and calamities, along with food, medicine, clothing and basic necessities of life, and efforts to provide stationery and toys for children in these areas, along with the presence of specialized teams in the Kermanshah and Sarpol Zahab earthquakes, the Lorestan and Khuzestan floods, as well as the Baluchistan floods, and providing relief to the dear people of the country have been other actions of Actover. Identifying deprived areas of the country approximately twice a year with the executive teams of Dr. Naraghi’s charity and the support of Actuator and Amad Ladiz in these areas, including South Khorasan (Firdous), Azerbaijan (Qara Aghaj), and the Ilam highlands.
Actover's social responsibilities
Developing the medical and hospital sector by identifying children in need of serious medical attention throughout the country and providing full support until the patient’s condition improves, and recently, Iraqi and Afghan children who suffered from war or genetic accidents, and thanks to Dr. Naraqi’s charitable support, we were able to introduce them to medical centers and begin their treatment. In general, any child from anywhere in the country and recently abroad who needs medical, surgical or pharmaceutical support is supported by Dr. Naraqi’s charity.
With the outbreak of COVID-19, in addition to providing personal protective clothing (PPE) and producing disinfectant solutions and donating them to medical centers and deprived areas, it also provided medicines such as Tamiflu and Kaletra and distributed them quickly in the first days of the outbreak. At the same time, it started preparations for the production of special Corona medicines with international manufacturers. This led to the finalization of the production process of these products in the country in the shortest possible time. In addition to self-sufficiency in production, it provides these products to our dear people with a capacity of more than 30 million favipiravir tablets and 300,000 vials of remdesivir per month, at a price of less than one-fifteenth. With the beginning of the global effort to provide the Corona vaccine, this company, as the first holder of the technical knowledge to produce this vaccine in the Middle East, succeeded in producing the Russian Sputnik vaccine in Iran.